The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $2,449,123 project grant to the Northern California Institute for Research and Education, Inc. (NCIRE) to conduct the "TBI Rehabilitation and Activation in Veterans (TRAIN-VETS)" research project. The grant, awarded on September 1, 2024, will fund a 4-year study to develop and evaluate innovative rehabilitation approaches for improving outcomes for veterans with traumatic...
The federal Project Grant award of $5,954,349.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a randomized controlled trial to optimize heart rate variability in combat veterans and service members with persistent post-concussion symptoms. The award was made to Virginia Commonwealth University (VCU), which is collaborating with the Palo Alto Veterans Institute for Research (Pavir) and the Richmond Institute for...
The University of Virginia will receive $748,422 under a three-year Project Grant award from the Department of the Army Medical Command. The award is funded through the Military Medical Research and Development program (CFDA 12.420). The University will quantify the relationship between brain biomechanics and head exposures relevant to warfighters. Insights gained from this research aim to guide the development of future injury prevention technologies. Specifically, the University seeks to...
The Defense Health Agency awarded a $6,325,327 project grant to the Tampa VA Research and Education Foundation, Inc. under the Military Medical Research and Development program (CFDA 12.420) to improve health care access and engagement for veterans and service members with traumatic brain injury morbidity over a 4-year period ending on September 29, 2027. As the prime grantee, the foundation will provide data identification, extraction, natural language processing, and data transformation...
The University of Virginia (UVA) received a $847,875 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, effective September 1, 2025 through August 31, 2028, will support research targeting Schwann cell-tumor microenvironment interactions in neurofibroma development. The federal grant funding will enable UVA to conduct advanced biomedical research aimed at transforming healthcare for military service members,...
This Project Grant award, valued at $2,411,921.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports cognitive rehabilitation research aimed at treating anger in veterans with traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD). The project will be conducted by Duke University's Office of Research Administration Division, a leading provider of advanced medical research to federal agencies....
This $309,279 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research study on traumatic brain injury (TBI) and psychological health conducted by Florida State University. The primary objectives are to adapt the Ohio State University TBI Identification Method and the STAIR-NT intervention for first responders with TBI, analyze the data, and disseminate the study findings. Key sub-award activities...
The Department of Defense's Defense Health Agency awarded a $623,003 Project Grant to Virginia Commonwealth University (VCU) under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from May 1, 2024 to April 30, 2027, will fund a longitudinal study to characterize the genetic architecture and risk factors for post-concussive symptoms, post-traumatic stress disorder, and alcohol use disorder in a military cohort. VCU has subawarded a portion of the grant to...
This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
The Defense Health Agency awarded a $3,995,791 project grant to Virginia Commonwealth University under the Military Medical Research and Development program (CFDA 12.420) to compare the attentional demands and functional outcomes of pattern recognition and direct myoelectric control in people with transradial amputation. VCU will conduct this research from September 2023 through September 2027 in Richmond, Virginia. Two subawards were also provided. Hanger Institute for Clinical Research and...
The Department of Defense's Defense Health Agency awarded a 4-year, $4,778,800 project grant to the University of Virginia (UVA) to conduct the "REACH Intervention for Caregivers of Veterans and Service Members with TBI: Efficacy and Implementation Planning Across the VA Polytrauma System of Care." This grant, funded under the Military Medical Research and Development (CFDA 12.420) program, aims to develop and evaluate the efficacy of the REACH caregiver support intervention for families impacted by traumatic brain injury (TBI). UVA will serve as the lead institution, partnering with the University of Utah, Tampa VA Research & Education Foundation, and Virginia Commonwealth University as subrecipients to implement the study, collect data, and develop an implementation plan. Key activities include finalizing the REACH intervention, conducting a clinical trial to assess its effectiveness, and creating a strategy to scale the program across the VA Polytrauma System of Care.